Even though personalized oncology is widely perceived as an imminent reality, few anticancer drugs are currently prescribed based upon predictive biomarkers.[1] Moreover, despite outstanding advances in molecular biology, the clinical development of most anticancer drugs is still based on conventional randomized studies that aim to detect statistically significant clinical benefits in unselected patients. Several factors underlie this fact, including the complexity of cancer, but probably one major cause is the lack of a robust methodology to discover candidate biomarkers.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iQ4wD1
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Blinatumomab is a bispecific T-cell engaging αCD19 antibody used in refractory or relapsed B-cell precursor acute lymphoblastic l...
-
About 540 million years ago a group of jellyfish washed ashore, died and fossilised – preserving evidence of the earliest example of an anim...
-
The pursuit for clarity in diagnostic and treatment pathways for the complex, chronic condition of myalgic encephalomyelitis/chronic fatigue...
-
Abstract Objective To study clinical profile and outcome in patients with methemoglobinemia following exposure to toxic colors during Ho...
-
Facial Nerve Clinic to Provide Comprehensive Personalized Care Newswise (press release) The program will treat patients with facial n...
-
Sarcoidosis is a multisystem granulomatous syndrome of unknown etiology with noncaseating epithelioid granulomas being the pathognomonic pat...
-
Acquired Vascular Tumors of the Head and Neck. Otolaryngol Clin North Am. 2017 Oct 26;: Authors: Persky M, Tran T Abstract Vascular...
-
Background. Sevoflurane is rarely used for the treatment of status asthmaticus. We report a case of sevoflurane hepatotoxicity in pregnancy ...
-
To survive in its sand fly vector, the trypanosomatid protozoan parasite Leishmania first attaches to the midgut to avoid excretion, but eve...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου